BOSTON--(BUSINESS WIRE)--Dana-Farber Cancer Institute, in partnership with Brigham and Women’s Hospital and Children’s Hospital Boston, was one of only three large stem cell transplant programs nationwide that consistently outperformed the expected one-year survival rate for unrelated donor stem cell transplants in the United States, according to an independent report from the Center for International Blood & Marrow Transplant Research (CIBMTR).
